Wenchen Pu

2.8k citations
40 papers · 1.6k · 1 hit paper · h-index 19

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Circular RNAs in diseases
    • RNA modifications and cancer
    • RNA Research and Splicing
    • Extracellular vesicles in disease
    • Signaling Pathways in Disease

Papers in

    • Signaling Pathways in Disease 7
    • Protein Degradation and Inhibitors 5
    • RNA modifications and cancer 5
    • RNA Research and Splicing 4
    • Circular RNAs in diseases 3

Wenchen Pu

40 papers receiving 1.6k citations

Hit Papers

Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance 2020 · 525 citations
5250+2+4Years since publication100200300400500

Peers

Wenchen Pu
Comparison fields: 5 of 103
  • Cancer Research 894
  • Molecular Biology 1.3k
  • Oncology 152
  • Immunology 116
  • Molecular Medicine 26
Replace Yubo Tang with:
Yubo Tang China
Peng Bai China
Al-Aliaa M. Sallam Egypt
Xupeng Bai China
Wenxia Xu China
Girijesh Kumar Patel United States
Shokooh Salimimoghadam Iran
Jiqin Lian China
Elham Baghbani Iran
Sanam Sadreddini Iran
Wenchen Pu relative to Yubo Tang China Yubo Tang's profile →
Citations per field
00.5×1.5×1.9×
Yubo Tang · 1×
Citations per year

Countries citing papers authored by Wenchen Pu

Since Specialization
Citations

This map shows the geographic impact of Wenchen Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenchen Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenchen Pu more than expected).

Fields of papers citing papers by Wenchen Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenchen Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenchen Pu. The network helps show where Wenchen Pu may publish in the future.

Co-authors

The 25 scholars most cited alongside Wenchen Pu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wenchen Pu Line = papers co-authored together Wenchen Pu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance
Hit paper breakdown →
2020525
2 2018115
3 2018110
4 202283
5 201878
6 201874
7 201866
8 201762
9 201842
10 201840
11 201438
12 201734
13 202430
14 201929
15 202028
16 201727
17 201919
18 201819
19 201918
20 202117

About Wenchen Pu

Wenchen Pu is a scholar working on Molecular Biology, Organic Chemistry, Cancer Research, Oncology and Pharmacology, having authored 40 papers that have together received 1.6k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (7 papers), Peptidase Inhibition and Analysis (7 papers), Protein Degradation and Inhibitors (5 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA Research and Splicing (4 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (894 citations), Molecular Biology (1.3k citations), Oncology (152 citations), Immunology (116 citations) and Molecular Medicine (26 citations). Wenchen Pu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Yong Peng, Jiao Li, Dan Sun, Jin Wang, Juan He, Chun Wang, Xuesha Liu, Yuquan Wei, Lunxu Liu and Jiankang Zhou. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cancer Letters, Journal of Medicinal Chemistry, Organic Chemistry Frontiers and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact